The role of stem cell mobilization regimen on lymphocyte collection yield in patients with multiple myeloma

Cytotherapy

Volumn 10, Issue 5, 2008, Pages 507-517

  Hiwase, Devendra K ^a,b   Hiwase, S ^a,b   Bailey, M ^c   Bollard, G ^b   Schwarer, A P ^b  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Autologous stem cell transplantation; Lymphocyte collection; Multiple myeloma

Indexed keywords

BUSULFAN; CARMUSTINE; CD34 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; MELPHALAN; PREDNISOLONE; PREDNISONE; VINCRISTINE;

ADULT; AGE; AGED; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DONOR LYMPHOCYTE INFUSION; DOSE RESPONSE; DRUG DOSE COMPARISON; FEMALE; HUMAN; HUMAN CELL; LEUKAPHERESIS; LOW DRUG DOSE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STEM CELL MOBILIZATION; SURVIVAL RATE;

EID: 53249111348     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240802165665     Document Type: Article

References (28)

1. Attal, M. and Harousseau, JL (1996) Stoppa AM et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Engl J Med, 335, pp. 91-97.
2. Kim, H., Sohn, HJ Kim, S. et al. (2006) Early lymphocyte recovery predicts longer survival after autologous peripheral blood stem cell transplantation in multiple myeloma. Bone Marrow Transplant, 37, pp. 1037-1042.
3. Porrata, LF, Gertz, MA Inwards, DJ et al. (2001) Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma. Blood, 98, pp. 579-585.
4. Porrata, LF, Litzow, MR Tefferi, A. et al. (2002) Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia. Leukemia, 16, pp. 1311-1318.
5. Schrama, JG, Rodenhuis, S. and de Gast, GC. (2003) Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer. Bone Marrow Transplant, 31, pp. 141-142.
6. Gordan, LN, Sugrue, MW Lynch, JW et al. (2003) Correlation of early lymphocyte recovery and progression-free survival after autologous stem-cell transplant in patients with Hodgkin's and non-Hodgkin's lymphoma. Bone Marrow Transplant, 31, pp. 1009-1013.
7. Porrata, LF and Inwards, DJ (2002) Micallef IN et al. Early lymphocyte recovery post-autologous haematopoietic stem cell transplantation is associated with better survival in Hodgkin's disease. Br J Haematol, 117, pp. 629-633.
8. Yoong, Y., Porrata, LF Inwards, DJ et al. (2005) The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphoma. Leuk Lymphoma, 46, pp. 1287-1294.
9. Siddiqui, MA, Markovic, SN Nevala, WK et al. (2006) Day 15 natural killer (NK) cell recovery predicts progression free survival after autologous stem cell transplantation in non-Hodgkin's lymphoma. ASH Annual Meeting Abstracts. Blood, 108, p. 2914.
10. Joao, C., Porrata, LF Inwards, DJ et al. (2006) Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma. Bone Marrow Transplant, 37, pp. 865-871.
11. Boulassel, MR, Herr, AL de B Edwards, MD et al. (2006) Early lymphocyte recovery following autologous peripheral stem cell transplantation is associated with better survival in younger patients with lymphoproliferative disorders. Hematology, 11, pp. 165-170.
12. Kim, H., Sohn, HJ Kim, SE et al. (2004) Lymphocyte recovery as a positive predictor of prolonged survival after autologous peripheral blood stem cell transplantation in T-cell non-Hodgkin's lymphoma. Bone Marrow Transplant, 34, pp. 43-49.
13. Porrata, LF, Gertz, MA Litzow, MR et al. (2005) Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis. Clin Cancer Res, 11, pp. 1210-1218.
14. Porrata, LF, Gertz, MA Geyer, SM et al. (2004) The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma. Leukemia, 18, pp. 1085-1092.
15. Porrata, LF, Litzow, MR Inwards, DJ et al. (2004) Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma. Bone Marrow Transplant, 33, pp. 291-298.
16. Hiwase, DK, Hiwase, S. Bailey, M. et al. (2008) Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma. Biol Blood Marrow Transplant, 14, pp. 116-124.
17. Blade, J., Samson, D. Reece, D. et al. (1998) Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant. Br J Haematol, 102, pp. 1115-1123.
18. Oliveira, MR, Hyashi, M. and Magalhaes-Silverman, M. (2002) Early lymphocyte recovery predicts for progression-free survival (PFS) in Hodgkin's lymphoma (HL) patients following autologous stem cell transplant (ASCT) using same ablative regimen. Blood, 100, p. 2551.
19. Ferrandina, G., Pierelli, L. Perillo, A. et al. (2003) Lymphocyte recovery in advanced ovarian cancer patients after high-dose chemotherapy and peripheral blood stem cell plus growth factor support: clinical implications. Clin Cancer Res, 9, pp. 195-200.
20. Holtan, SG, Porrata, LF Inwards, DJ et al. (2004) Time interval from last chemotherapy to stem cell collection correlates with peripheral blood absolute lymphocyte count at apheresis and survival post-autologous stem cell transplantation in non-Hodgkin's lymphoma. ASH Annual Meeting Abstracts. Blood, 104, p. 2927.
21. Holtan, SG, Porrata, LF Inwards, DJ et al. (2006) Timing of autologous stem cell transplantation from last chemotherapy affects lymphocyte collection and survival in non-Hodgkin lymphoma. Br J Haematol, 133, pp. 628-633.
22. Hiwase, DK, Bollard, G. Hiwase, S. et al. (2007) Intermediate-dose CY and G-CSF more efficiently mobilize adequate numbers of PBSC for tandem autologous PBSC transplantation compared with low-dose CY in patients with multiple myeloma. Cytotherapy, 9, pp. 539-547.
23. Porrata, LF, Hayman, SR Gertz, MA et al. (2005) The role of stem cell mobilization regimen on lymphocyte collection yield and survival after autologous hematopoietic stem cell transplantation in multiple myeloma. ASH Annual Meeting Abstracts. Blood, 106, p. 1174.
24. Porrata, LF, Gastineau, DA Pineda, A. et al. (2004) Increasing the number of apheresis collections increases lymphocyte collection and affects survival after autologous stem cell transplantation for non-Hodgkin lymphoma. Ash Annual Meeting Abstracts. Blood, 104, p. 892.
25. Theilgaard-Monch, K., Raaschou-Jensen, K. Palm, H. et al. (2001) Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts. Bone Marrow Transplant, 28, pp. 1073-1082.
26. Porrata, LF, Gastineau, DA Padley, D. et al. (2003) Re-infused autologous graft natural killer cells correlates with absolute lymphocyte count recovery after autologous stem cell transplantation. Leuk Lymphoma, 44, pp. 997-1000.
27. Condomines, M., Quittet, P. Lu, ZY et al. (2006) Functional regulatory T cells are collected in stem cell autografts by mobilization with high-dose cyclophosphamide and granulocyte colony-stimulating factor. J Immunol, 176, pp. 6631-6639.
28. Tayebi, H., Kuttler, F. Saas, P. et al. (2001) Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells. Exp Hematol, 29, pp. 458-470.